Ticker
EU regulator green-lights Johnson & Johnson vaccine
By EUobserver
The European Medicines Agency on Thursday recommended granting conditional marketing authorisation to the Covid-19 vaccine of pharmaceutical company Johnson & Johnson, in people 18 years old and upwards. This is the first vaccine which can be used as a single dose. Clinical trials showed that the vaccine had a 67-percent efficacy.